Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 17.583.14-40.091,061.31222.71

What is the latest EBIT Growth ratio of VENUS REMEDIES ?

The latest EBIT Growth ratio of VENUS REMEDIES is 17.58 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202417.58
Mar20233.14
Mar2022-40.09
Mar20211,061.31
Mar2020222.71

How is EBIT Growth of VENUS REMEDIES Trending?

Years EBIT Growth % Change
Mar2024 17.58
459.87
Mar2023 3.14
Positive
Mar2022 -40.09
Negative
Mar2021 1061.31
376.54
Mar2020 222.71 -

Other Financial Ratios of VENUS REMEDIES


Compare EBIT Growth ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹424.0 Cr 6.5% 2.1% -21.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,848.0 Cr 2.7% -2.4% 49.5% Stock Analytics
DIVIS LABORATORIES ₹165,923.0 Cr 2.9% 6.2% 64.2% Stock Analytics
CIPLA ₹121,796.0 Cr 1% 6.4% 28.7% Stock Analytics
DR REDDYS LABORATORIES ₹101,919.0 Cr 1% -2.3% 6% Stock Analytics
ZYDUS LIFESCIENCES ₹98,072.6 Cr 2.4% -1.1% 53.4% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

6.5%

2.1%

-21.1%

SENSEX

0.2%

-0.2%

21.6%


You may also like the below Video Courses